CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
74.86
-1.00 (-1.32%)
Sep 2, 2026, 10:59 AM EDT - Market open
CG Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Reiterates $90 | Buy | Reiterates | $90 | +20.22% | Aug 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $93 | Buy | Reiterates | $93 | +24.23% | Aug 17, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $85 | Buy | Maintains | $85 | +13.55% | Aug 11, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $108 | Buy | Maintains | $108 | +44.27% | Aug 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $105 | Buy | Reiterates | $105 | +40.26% | Aug 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $82 → $85 | Buy | Reiterates | $82 → $85 | +13.55% | Aug 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $81 → $79 | Buy | Maintains | $81 → $79 | +5.53% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $87 → $88 | Buy | Reiterates | $87 → $88 | +17.55% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.